This resource is designed to introduce (or reintroduce) clinicians to the value of stool-based testing for colorectal cancer. It explains the different types of stool-based tests available—Fecal Immunochemical Tests (FIT), High-Sensitivity Fecal Occult Blood Tests (HS-gFOBT) and FIT-DNA testing—and provides guidance on implementing high quality stool-based screening programs. The resource now includes information on sensitivity and specificity for many of the most commonly used tests.
We would like to thank the following individuals, many from the NCCRT Professional Education and Practice Implementation Task Group, for reviewing past and current versions of this resource and contributing to this work: James Allison, Kim Andrews, Barry Berger, Durado Brooks, Gloria Coronado, Debbie Kirkland, Theodore Levin, Dorothy Lane, Laura Makaroff, Marion Nadel, Kerstin Ohlander, Mike Potter, Robert Smith, and Richard Wender. We’d also like to thank the Comprehensive Cancer Control Program National Partners for providing funding support.
Explore More
![Image for Blue Star Conversations – May 29, 2024](https://nccrt.org/wp-content/uploads/2023/10/iStock-1319068502-scaled.jpg)
Blue Star Conversations – May 29, 2024
Learn about how health systems can use their EHR to consistently and better target those who may need genetic testing.
![Image for Increasing Colorectal Cancer Screening Among LGBTQ+ Communities Brief](https://nccrt.org/wp-content/uploads/2019/03/Copy-of-Web-Title.png)
Increasing Colorectal Cancer Screening Among LGBTQ+ Communities Brief
Learn actions you can take to reduce colorectal cancer disparities rates in LGBTQ+ communities.
![Image for 2023 Lead Time Messaging Guidebook](https://nccrt.org/wp-content/uploads/2023/11/Lead-Time-Messaging-Guidebook.jpg)
2023 Lead Time Messaging Guidebook
This Guidebook is intended to provide you with information and tools to motivate individuals at average and heightened risk for CRC to discuss screening prior to the recommended screening age. Our belief is that this will increase the likelihood that they will prioritize getting screened on-time for CRC.